Pfizer Receivables 2010-2025 | PFE

Pfizer receivables for the quarter ending March 31, 2025 were $11.845B, a 7.79% increase year-over-year.

  • Pfizer receivables for 2024 were $11.463B, a 0.89% decline from 2023.
  • Pfizer receivables for 2023 were $11.566B, a 5.61% increase from 2022.
  • Pfizer receivables for 2022 were $10.952B, a 4.59% decline from 2021.

Pfizer Receivables 2010-2025 | PFE

  • Pfizer receivables for 2024 were $11.463B, a 0.89% decline from 2023.
  • Pfizer receivables for 2023 were $11.566B, a 5.61% increase from 2022.
  • Pfizer receivables for 2022 were $10.952B, a 4.59% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$751.6B
Johnson & Johnson (JNJ)$377.5B
AbbVie (ABBV)$339.9B
Novo Nordisk (NVO)$307.8B
Roche Holding AG (RHHBY)$258.2B
Novartis AG (NVS)$255.6B
Merck (MRK)$209.3B
Sanofi (SNY)$119.2B
Bayer (BAYRY)$31.4B
Innoviva (INVA)$1.2B